HydRegen Raises $8M for Cleaner Chemical Manufacturing

Oxford-based HydRegen has raised $8 million in the first close of its Series A to scale enzyme-based catalysts that could replace some energy-intensive chemical manufacturing processes.

What happened

The round was led by Genoa Ventures with participation from Clean Growth Fund, First Imagine! Ventures and other investors. HydRegen develops biocatalysts designed to perform chemical transformations using enzymes under milder conditions than some conventional industrial processes. Its approach can potentially reduce reliance on precious-metal catalysts, high temperatures and other costly inputs. The company plans to expand work with pharmaceutical and specialty-chemical customers and enter markets including agrochemicals, materials and bulk chemicals. Because this is a first close, the announced amount may not represent the eventual full Series A.

Why it matters

Chemical manufacturing consumes significant energy and often depends on expensive or supply-constrained catalysts. Enzymes can offer more selective reactions under lower-temperature conditions, potentially reducing waste and energy use if they remain stable and cost-effective at scale.

The bigger picture

Industrial biotechnology frequently struggles in the transition from laboratory performance to large-volume production. HydRegen's commercial opportunity depends on demonstrating repeatability, catalyst lifetime and economics across real manufacturing processes.